A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo

類似資料

• A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
  著者:: Zhu, Jingyu, 等
  出版事項: (2014)
• Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
  著者:: Zhu, Jingyu, 等
  出版事項: (2019)
• A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway
  著者:: Zhang, Zubin, 等
  出版事項: (2016)
• Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway
  著者:: Zhang, Zubin, 等
  出版事項: (2016)
• SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway
  著者:: Han, Kunkun, 等
  出版事項: (2015)